Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis

J. L. Davis, I. Taskintuna, W. R. Freeman, D. V. Weinberg, W. J. Feuer and R. E. Leonard
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Fla, USA.

OBJECTIVE: To describe intraocular inflammation due to treatment with intravenous cidofovir dihydrate for cytomegalovirus retinitis. DESIGN: Retrospective cohort. SETTING: Three university outpatient ophthalmology clinics. PATIENTS: All patients treated with intravenous cidofovir therapy before October 31, 1996. INTERVENTION: Treatment with intravenous cidofovir was given according to standardized protocols. Intraocular inflammation was treated according to the best medical judgment. MAIN OUTCOME MEASURES: The presence of new intraocular inflammation, the severity of inflammation, visual acuity, and intraocular pressure. RESULTS: Eleven cases of iritis (26%) occurred among 43 patients. In 6 cases, the iritis was bilateral. Patients who experienced iritis were more likely to have been previously treated for cytomegalovirus retinitis (P = .03), to be diabetic (P = .05), or to be receiving protease inhibitors (P < .001). Four patients and 15 control subjects had also taken rifabutin (P = .70). The onset of iritis occurred at a mean (+/-SD) of 4.9 +/- 1.8 days after a cidofovir dose and after a mean (+/-SD) of 4.2 +/- 1.6 doses of cidofovir. Six eyes of 4 patients had hypotony. Five eyes of 5 patients had a persistent decrease in visual acuity of at least 2 Snellen lines. CONCLUSIONS: Acute intraocular inflammation may occur with or without hypotony after intravenous cidofovir therapy, similar to the reactions seen after intravitreous administration. Although the manifestations may be severe, they are manageable with topical corticosteroid therapy in most cases. Cidofovir therapy can be continued in some patients if medical necessity warrants, but recurrent inflammation or permanent hypotony may occur.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Ljungman et al.
Blood 2001;97:388-392.
ABSTRACT | FULL TEXT  

Uveitis in HIV positive patients
CUNNINGHAM
Br. J. Ophthalmol. 2000;84:233-236.
FULL TEXT  

A systematic review of drug induced ocular reactions in diabetes
Hampson and Harvey
Br. J. Ophthalmol. 2000;84:144-149.
ABSTRACT | FULL TEXT  

Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis
Ambati et al.
Br. J. Ophthalmol. 1999;83:1153-1158.
ABSTRACT | FULL TEXT  

Cidofovir and Experimental Herpetic Stromal Disease
Kaufman et al.
Arch Ophthalmol 1999;117:925-928.
ABSTRACT | FULL TEXT  

Treatment of immune recovery vitritis with local steroids
Henderson and Mitchell
Br. J. Ophthalmol. 1999;83:540-545.
ABSTRACT | FULL TEXT  

Ocular Manifestations of HIV Infection
Cunningham and Margolis
NEJM 1998;339:236-244.
FULL TEXT  

Guidelines for the Treatment of Cytomegalovirus Diseases in Patients With AIDS in the Era of Potent Antiretroviral Therapy: Recommendations of an International Panel
Whitley et al.
Arch Intern Med 1998;158:957-969.
ABSTRACT | FULL TEXT  

Clinical Failure of CMV Retinitis With Intravitreal Cidofovir Is Associated With Antiviral Resistance
Smith et al.
Arch Ophthalmol 1998;116:178-185.
ABSTRACT | FULL TEXT